Global Pharmaceutical Industry - Statistics & Facts
Statistics and facts about the pharmaceutical industry worldwide
The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is inarguable. In 2014, total pharmaceutical revenues worldwide had exceeded one trillion U.S. dollars for the first time. North America is responsible for the largest portion of these revenues, due to the leading role of the U.S. pharmaceutical industry. However, as in many other industries, the Chinese pharmaceutical sector has shown the highest growth rates over previous years.
Still, the leading pharmaceutical companies come from the United States and Europe. Based on prescription sales, NYC-based Pfizer is the world’s largest pharmaceutical company. In 2016, the company generated some 52.8 billion U.S. dollars in pure pharmaceutical sales. Other top global players from the United States include Johnson & Johnson, Merck and AbbVie. Novartis and Roche from Switzerland, GlaxoSmithKline and AstraZeneca from the United Kingdom, and French Sanofi are the European big five.
Branded, patented medicines by far make up the largest share of pharmaceutical revenues. Humira, an anti-inflammatory drug, generated over 16 billion U.S. dollars of revenue worldwide in 2016. Oncologics continue to be one of the three leading therapeutic classes based on revenue. In 2015, cancer drugs made almost 79 billion U.S. dollars of revenue globally. Other major therapy classes were pain drugs, antihypertensives and antidiabetics.
More than any other industry, the pharmaceutical sector is highly dependent on its research and development segment. Some pharmaceutical companies invest 20 percent and more of their revenues in R&D measures. The United States is a traditional stronghold of pharmaceutical innovation. The origin of most new substances introduced to the market can be traced back to the United States. Because of the steady loss of patent protection, the invention of new drugs is of vital importance for the pharmaceutical industry. Revenue losses due to patent expiry often are very significant, as can be seen with Pfizer’s Lipitor from 2012 on.
Picture: freeimages.com / forwardcom
|Companies and Products||Values||Statistic|
|℞ Sales of Pfizer||47.4bn USD||Details →|
|Net income of Johnson & Johnson||15.94bn USD||Details →|
|Sales of Humira||14.95bn USD||Details →|
|Novartis AG total revenue||48.5bn USD||Details →|
|Regeneron's R&D spending as revenue share in 2015||60.3%||Details →|
|Global gout therapy market||1.3bn USD||Details →|
|Pharma company with the highest number of employees worldwide||Johnson & Johnson||Details →|
|Top global animal health company||Zoetis||Details →|
- Pharmaceutical market: worldwide revenue 2001-2015+Pharmaceutical market: worldwide revenue 2001-2015
Revenue of the worldwide pharmaceutical market from 2001 to 2015 (in billion U.S. dollars)
- Top 10 global pharmaceutical markets: growth 2010-2015+Top 10 global pharmaceutical markets: growth 2010-2015
Growth of top 10 national pharmaceutical markets worldwide from 2010 to 2015*
- Top 50 pharmaceutical companies - Rx sales and R&D spending 2015+Top 50 pharmaceutical companies - Rx sales and R&D spending 2015
Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2015 (in billion U.S. dollars)
- Top AIDS drugs worldwide based on revenue 2014-2016Top AIDS drugs worldwide based on revenue 2014-2016
- Global animal health market 2002-2016Global animal health market 2002-2016
- Revenue of top 20 respiratory brands in the U.S. 2016Revenue of top 20 respiratory brands in the U.S. 2016
- Boehringer Ingelheim's top prescription drugs 2011-2016Boehringer Ingelheim's top prescription drugs 2011-2016
- OTC medication retail sales in the U.S. 1965-2016OTC medication retail sales in the U.S. 1965-2016